News

March 28, 2007 - With an estimated 70 million Americans currently living with cardiovascular disease, the demand for services in the catheterization ("cath") lab continues to escalate. In fact, an...

Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary...

March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment...